Newland JW - Search Results

1

Genotypic and phenotypic characterization of an aroD deletion-attenuated Escherichia coli K12-Shigella flexneri hybrid vaccine expressing S. flexneri 2a somatic antigen.

Newland JW, Hale TL, Formal SB. Newland JW, et al. Vaccine. 1992;10(11):766-76. doi: 10.1016/0264-410x(92)90512-i. Vaccine. 1992. PMID: 1441732

2

Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine.

Venkatesan MM, Hartman AB, Newland JW, Ivanova VS, Hale TL, McDonough M, Butterton J. Venkatesan MM, et al. Among authors: newland jw. Infect Immun. 2002 Jun;70(6):2950-8. doi: 10.1128/IAI.70.6.2950-2958.2002. Infect Immun. 2002. PMID: 12010984 Free PMC article.

3

Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.

Kotloff KL, Herrington DA, Hale TL, Newland JW, Van De Verg L, Cogan JP, Snoy PJ, Sadoff JC, Formal SB, Levine MM. Kotloff KL, et al. Among authors: newland jw. Infect Immun. 1992 Jun;60(6):2218-24. doi: 10.1128/iai.60.6.2218-2224.1992. Infect Immun. 1992. PMID: 1587589 Free PMC article. Clinical Trial.

4

Intracellular spread of Shigella flexneri associated with the kcpA locus and a 140-kilodalton protein.

Pál T, Newland JW, Tall BD, Formal SB, Hale TL. Pál T, et al. Among authors: newland jw. Infect Immun. 1989 Feb;57(2):477-86. doi: 10.1128/iai.57.2.477-486.1989. Infect Immun. 1989. PMID: 2643571 Free PMC article.

5

Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.

Kotloff KL, Losonsky GA, Nataro JP, Wasserman SS, Hale TL, Taylor DN, Newland JW, Sadoff JC, Formal SB, Levine MM. Kotloff KL, et al. Among authors: newland jw. Vaccine. 1995 Apr;13(5):495-502. doi: 10.1016/0264-410x(94)00011-b. Vaccine. 1995. PMID: 7639017 Clinical Trial.

6

Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2.

Taylor DN, Phillip DF, Zapor M, Trofa A, Van de Verg L, Hartman A, Bendiuk N, Newland JW, Formal SB, Sadoff JC, et al. Taylor DN, et al. Among authors: newland jw. Vaccine. 1994 May;12(6):565-8. doi: 10.1016/0264-410x(94)90318-2. Vaccine. 1994. PMID: 8036831 Clinical Trial.

7

Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dysenteriae type 1 that retains virulence.

Neill RJ, Gemski P, Formal SB, Newland JW. Neill RJ, et al. Among authors: newland jw. J Infect Dis. 1988 Oct;158(4):737-41. doi: 10.1093/infdis/158.4.737. J Infect Dis. 1988. PMID: 3049838

8

Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.

O'Brien AD, Newland JW, Miller SF, Holmes RK, Smith HW, Formal SB. O'Brien AD, et al. Among authors: newland jw. Science. 1984 Nov 9;226(4675):694-6. doi: 10.1126/science.6387911. Science. 1984. PMID: 6387911

9

Cloning of genes for production of Escherichia coli Shiga-like toxin type II.

Newland JW, Strockbine NA, Neill RJ. Newland JW, et al. Infect Immun. 1987 Nov;55(11):2675-80. doi: 10.1128/iai.55.11.2675-2680.1987. Infect Immun. 1987. PMID: 2822579 Free PMC article.

10

Genotypic variation in pathogenic Escherichia coli O157:H7 isolated from patients in Washington, 1984-1987.

Tarr PI, Neill MA, Clausen CR, Newland JW, Neill RJ, Moseley SL. Tarr PI, et al. Among authors: newland jw. J Infect Dis. 1989 Feb;159(2):344-7. doi: 10.1093/infdis/159.2.344. J Infect Dis. 1989. PMID: 2644374 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters